Jodi Devlin

Insider Reports History

Location
Westminster, CO
Signature
/s/ Mary Szela, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jodi Devlin:

Company Role Class Num Shares Value Price $ Report Date Ownership
TriSalus Life Sciences, Inc. Chief of Clinical Operations Common Stock 100,571 $476,706 $4.74 24 Nov 2025 Direct
TriSalus Life Sciences, Inc. Chief of Clinical Operations Employee Stock Option (right to buy) 463,750 24 Nov 2025 Direct

Insider Reports Filed by Jodi Devlin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TLSI TriSalus Life Sciences, Inc. 24 Nov 2025 2 $0 4 Chief of Clinical Operations 25 Nov 2025, 15:56
TLSI TriSalus Life Sciences, Inc. 19 May 2025 2 +$100,321 4 Chief of Clinical Operations 21 May 2025, 17:31
TLSI TriSalus Life Sciences, Inc. 18 Feb 2025 1 $0 4 Chief of Clinical Operations 19 Feb 2025, 17:37
TLSI TriSalus Life Sciences, Inc. 27 Jan 2025 2 $0 4 Chief of COMMERC. OPERATIONS 29 Jan 2025, 18:00
TLSI TriSalus Life Sciences, Inc. 12 Feb 2024 2 $0 4 PRESIDENT, COMMERC. OPERATIONS 14 Feb 2024, 18:19
TLSI TriSalus Life Sciences, Inc. 30 Aug 2023 1 $0 4 President, Therapeutics 31 Aug 2023, 21:04
TLSI TriSalus Life Sciences, Inc. 28 Aug 2023 0 $0 3 President, Therapeutics 31 Aug 2023, 21:00